ADHD in Children and Adolescents: Barriers to Ethical and Successful Treatment

This review provides a comprehensive analysis of attention deficit hyperactivity disorder (ADHD), neurodevelopmental characterized by inattention, hyperactivity, or impulsivity. The global prevalence the ranges from 2% to 7%, with an average around 5%. ADHD affects individuals all ages, symptoms typically becoming visible as early 3 years. range mild severe and may persist into adulthood. variety demographic groups, including differences in age, gender, race, ethnicity, varying effects, prevalence, treatment options among these groups. Treatment for behavioral interventions prescription medication, number medications available on market treating ADHD. also highlights issues relapse safety concerns associated use well challenges diversity socioeconomic barriers diagnosis disorder.